Multiple Sclerosis Clinical Trials in Birmingham, Alabama
5 studies are recruiting for multiple sclerosis in Birmingham, Alabama right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
- Locations
- 52 in total
- Run by
- National Cancer Institute (NCI)
-
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting
- Stage
- Not phased
- Ages
- 18 and older
- Site
- TG Therapeutics Investigational Trial Site, Birmingham, Alabama
- Locations
- 109 in total
- Run by
- TG Therapeutics, Inc.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
The primary objective of this study is to measure the concentration and the regional brain distribution of activated brain microglia/macrophages using the PET radiopharmaceutical [F-18]DPA-714 in individuals with chronic pain and fatigue suspected to be associated with neuroinflammation. The PET tr…
- Stage
- Phase 1
- Ages
- 18 to 65
- Site
- University of Alabama at Birmingham Medical Center, Birmingham, Alabama
- Run by
- University of Alabama at Birmingham
-
Care in Multiple Sclerosis (MS)
This study is structured around three main aims. In Aim 1, investigators will conduct community-based participatory research (CBPR) to develop culturally tailored methods to assess childhood adversity in multiple sclerosis (MS). Aim 2 will investigate the impact of childhood adversity on MS outcome…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Alabama at Birmingham, Birmingham, Alabama
- Locations
- 6 in total
- Run by
- NYU Langone Health
-
AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- 354 School of Health Professions Building, Birmingham, Alabama
- Run by
- University of Alabama at Birmingham
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.